Can You Split the Dosing of Daratumumab?

Can You Split the Dosing of Daratumumab?

AnnualMeeting2017

3 years
4,720 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Mark Wildgust, Vice President of Global Medical Affairs for Janssen Oncology explains a common question that's usually asked regarding the CASTOR/POLLUX study, which is whether or not you can split the dosing of daratumumab. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL. Abstract 8006: Efficacy of daratumumab in combination with lenalidomide plus dexamethasone (DRd) or bortezomib plus dexamethasone (DVd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk status
Up Next Autoplay